← Leaderboards
Barbara Olszewska-Pazdrak
Chrysalis Biotherapeutics, Inc.
$199,757
Attributed
$199,757
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$199,757 · 1
By mechanism
N43$199,757 · 1
Top collaborators
No co-investigators on record.
Most similar at Chrysalis Biotherapeutics, Inc.
Same institution · by research overlap
- Darrell H. Carney$3,043,203
- Barbara Maria Olszewska-Pazdrak$648,663
- Laurie E Sower$2,394,540
Others in their field
Top investigators on “Adult Glioblastoma”
- John H Sampson · Duke University$25,704,463
- David Heimbrook · Leidos Biomedical Research, Inc.$20,000,000
- Melissa L Bondy · Stanford University$15,621,255
- Margaret R. Wrensch · University Of California San Francisco$11,743,624
- Kevin M Shannon · University Of California San Francisco$11,015,561
- David W. Clapp · Indiana University Indianapolis$11,015,561
Research focus
Adult GlioblastomaAdverse EffectsApoptosisAstrocytesAstrocytomaAstrogliosisBacteremiaBiological AvailabilityBlood - Brain Barrier AnatomyBlood VesselsBrainBrain TissueCadherin 5CaliberCancer CellCancer PatientCell Adhesion MoleculesCell ProliferationCell SurvivalCentral Nervous System NeoplasmsCerebral AtrophyClinical TrialsDiabetic Foot UlcerAdhesions